Circio to participate in the Annual European Life Sciences CEO Forum in Zürich

Oslo, Norway, 27 February 2024 – Circio Holding ASA (OSE: CRNA) announces that CFO Lubor Gaal is invited as a panel discussant at the 17th Annual European Life Sciences CEO Forum

Dr Lubor Gaal will participate in the conference discussion panel on gene therapy in rare disease:

17th Annual European Life Sciences CEO Forum, Zurich, Switzerland
Panel: Rare & Orphan Therapies Panel: Gene Therapy & Other Modalities
Presenter: Lubor Gaal, CFO
Date: 28 February 2024
Time: 11:50 CET

***